The report is scheduled to ship the week of April 22, 2012 and continues the firm's coverage of the dye sensitized cell (DSC) photovoltaics space that dates back to 2008. Additional details about the report are available on the firm's website at http://nanomarkets.net/market_reports/report/dye_sensitized_cell_markets_2012
The firm will also be releasing an update of its analysis of the organic photovoltaics market this month.
About the report:
In the past two years, the dye sensitized cell (DSC) market has come of age and has moved out of its R&D phase. The performance of DSCs is now comparable with amorphous silicon PV, but with much more potential than a-Si for performance improvements. DSC's also offers an ability to be deployed on flexible substrates and perform under non-peak insolation.
This report provides an in-depth market analysis of recent developments in DSCs, examining the meaning of the latest products, strategies and technical developments. We identify how performance improvements are likely to help grow addressable markets for DSC and where these new markets are to be found. Specifically, we examine the potential for DSC in the BIPV sector and how DSC is likely to do in a world in which solar energy is not the hot topic that it was a few years ago.
The report also appraises the commercial significance of the developments that have taken place in the DSC over the past year; for example, attempts to reduce the cost of dyes and electrodes. And it also includes NanoMarkets' assessments of the strategies of leading firms active in the DSC space. And, as always with NanoMarkets reports, this report also contains granular forecasts of DSC panel and materials shipments in volume and value terms.
Companies considered for the report will include pure play DSC companies such as 3GSolar, Dyesol and its subsidiaries and alliances, Fujikura, G24 Innovations, NLAB Solar, Oxford Photovoltaics, Peccell, Solaronix and SolarPrint along with large specialty chemical company strategies in the DSC space such as BASF, Everlight, Merck and Showa Denko.
